Federal Register / Vol. 79, No. 233 / Thursday, December 4, 2014 / Notices 72005 

ESTIMATED ANNUALIZED BURDEN HOURS

Form name Type of respondents Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total annual 

burden hours 

IMAT Awardee Interview ................... IMAT Awardees ............................... 100 1 1 100 

Evaluation Web-based Survey .......... IMAT Awardees, and other NIH 

Awardees (Comparison group).

900 1 30/60 450 

Tech End Users Interview ................. Technology End-Users .................... 50 1 30/60 25 

Dated: November 24, 2014. 

Karla Bailey, 

NCI Project Clearance Liaison, National 

Institutes of Health. 

[FR Doc. 2014–28498 Filed 12–3–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Current List of HHS-Certified 

Laboratories and Instrumented Initial 

Testing Facilities Which Meet Minimum 

Standards To Engage in Urine Drug 

Testing for Federal Agencies 

AGENCY: Substance Abuse and Mental 

Health Services Administration, HHS. 

ACTION: Notice. 

SUMMARY: The Department of Health and 

Human Services (HHS) notifies federal 

agencies of the laboratories and 

Instrumented Initial Testing Facilities 

(IITF) currently certified to meet the 

standards of the Mandatory Guidelines 

for Federal Workplace Drug Testing 

Programs (Mandatory Guidelines). The 

Mandatory Guidelines were first 

published in the Federal Register on 

April 11, 1988 (53 FR 11970), and 

subsequently revised in the Federal 

Register on June 9, 1994 (59 FR 29908); 

September 30, 1997 (62 FR 51118); 

April 13, 2004 (69 FR 19644); November 

25, 2008 (73 FR 71858); December 10, 

2008 (73 FR 75122); and on April 30, 

2010 (75 FR 22809). 

A notice listing all currently HHScertified laboratories and IITFs is 

published in the Federal Register 

during the first week of each month. If 

any laboratory or IITF certification is 

suspended or revoked, the laboratory or 

IITF will be omitted from subsequent 

lists until such time as it is restored to 

full certification under the Mandatory 

Guidelines. 

If any laboratory or IITF has 

withdrawn from the HHS National 

Laboratory Certification Program (NLCP) 

during the past month, it will be listed 

at the end and will be omitted from the 

monthly listing thereafter. 

This notice is also available on the 

Internet at http://beta.samhsa.gov/

workplace. 

FOR FURTHER INFORMATION CONTACT: 

Giselle Hersh, Division of Workplace 

Programs, SAMHSA/CSAP, Room 7– 

1051, One Choke Cherry Road, 

Rockville, Maryland 20857; 240–276– 

2600 (voice), 240–276–2610 (fax). 

SUPPLEMENTARY INFORMATION: The 

Mandatory Guidelines were initially 

developed in accordance with Executive 

Order 12564 and section 503 of Public 

Law 100–71. The ‘‘Mandatory 

Guidelines for Federal Workplace Drug 

Testing Programs,’’ as amended in the 

revisions listed above, requires strict 

standards that laboratories and IITFs 

must meet in order to conduct drug and 

specimen validity tests on urine 

specimens for federal agencies. 

To become certified, an applicant 

laboratory or IITF must undergo three 

rounds of performance testing plus an 

on-site inspection. To maintain that 

certification, a laboratory or IITF must 

participate in a quarterly performance 

testing program plus undergo periodic, 

on-site inspections. 

Laboratories and IITFs in the 

applicant stage of certification are not to 

be considered as meeting the minimum 

requirements described in the HHS 

Mandatory Guidelines. A HHS-certified 

laboratory or IITF must have its letter of 

certification from HHS/SAMHSA 

(formerly: HHS/NIDA), which attests 

that it has met minimum standards. 

In accordance with the Mandatory 

Guidelines dated November 25, 2008 

(73 FR 71858), the following HHScertified laboratories and IITFs meet the 

minimum standards to conduct drug 

and specimen validity tests on urine 

specimens: 

HHS-Certified Instrumented Initial 

Testing Facilities 

Gamma-Dynacare Medical Laboratories, 

6628 50th Street NW., Edmonton, AB 

Canada T6B 2N7, 780–784–1190 

HHS-Certified Laboratories 

ACM Medical Laboratory, Inc., 160 

Elmgrove Park, Rochester, NY 14624, 

585–429–2264 

Aegis Analytical Laboratories, Inc., 345 

Hill Ave., Nashville, TN 37210, 615– 

255–2400, (Formerly: Aegis Sciences 

Corporation, Aegis Analytical 

Laboratories, Inc., Aegis Analytical 

Laboratories) 

Alere Toxicology Services, 1111 Newton 

St., Gretna, LA 70053, 504–361–8989/ 

800–433–3823, (Formerly: Kroll 

Laboratory Specialists, Inc., 

Laboratory Specialists, Inc.) 

Alere Toxicology Services, 450 

Southlake Blvd., Richmond, VA 

23236, 804–378–9130, (Formerly: 

Kroll Laboratory Specialists, Inc., 

Scientific Testing Laboratories, Inc.; 

Kroll Scientific Testing Laboratories, 

Inc.) 

Baptist Medical Center-Toxicology 

Laboratory, 11401 I–30, Little Rock, 

AR 72209–7056, 501–202–2783, 

(Formerly: Forensic Toxicology 

Laboratory Baptist Medical Center) 

Clinical Reference Lab, 8433 Quivira 

Road, Lenexa, KS 66215–2802, 800– 

445–6917 

DrugScan, Inc., 200 Precision Road, 

Suite 200, Horsham, PA 19044, 800– 

235–4890 

ElSohly Laboratories, Inc., 5 Industrial 

Park Drive, Oxford, MS 38655, 662– 

236–2609 

Fortes Laboratories, Inc., 25749 SW., 

Canyon Creek Road, Suite 600, 

Wilsonville, OR 97070, 503–486–1023 

Gamma-Dynacare Medical 

Laboratories *, A Division of the 

Gamma-Dynacare Laboratory 

Partnership, 245 Pall Mall Street, 

London, ONT, Canada N6A 1P4, 519– 

679–1630 

Laboratory Corporation of America 

Holdings, 7207 N. Gessner Road, 

Houston, TX 77040, 713–856–8288/

800–800–2387 

Laboratory Corporation of America 

Holdings, 69 First Ave., Raritan, NJ 

08869, 908–526–2400/800–437–4986, 

(Formerly: Roche Biomedical 

Laboratories, Inc.) 

Laboratory Corporation of America 

Holdings, 1904 Alexander Drive, 

mstockstill on DSK4VPTVN1PROD with NOTICES

72006 Federal Register / Vol. 79, No. 233 / Thursday, December 4, 2014 / Notices 

Research Triangle Park, NC 27709, 

919–572–6900/800–833–3984, 

(Formerly: LabCorp Occupational 

Testing Services, Inc., CompuChem 

Laboratories, Inc.; CompuChem 

Laboratories, Inc., A Subsidiary of 

Roche Biomedical Laboratory; Roche 

CompuChem Laboratories, Inc., A 

Member of the Roche Group) 

Laboratory Corporation of America 

Holdings, 1120 Main Street, 

Southaven, MS 38671, 866–827–8042/ 

800–233–6339, (Formerly: LabCorp 

Occupational Testing Services, Inc.; 

MedExpress/National Laboratory 

Center) 

LabOne, Inc. d/b/a Quest Diagnostics, 

10101 Renner Blvd., Lenexa, KS 

66219, 913–888–3927/800–873–8845, 

(Formerly: Quest Diagnostics 

Incorporated; LabOne, Inc.; Center for 

Laboratory Services, a Division of 

LabOne, Inc.) 

MedTox Laboratories, Inc., 402 W. 

County Road D, St. Paul, MN 55112, 

651–636–7466/800–832–3244 

MetroLab-Legacy Laboratory Services, 

1225 NE 2nd Ave., Portland, OR 

97232, 503–413–5295/800–950–5295 

Minneapolis Veterans Affairs Medical 

Center, Forensic Toxicology 

Laboratory, 1 Veterans Drive, 

Minneapolis, MN 55417, 612–725– 

2088 

National Toxicology Laboratories, Inc., 

1100 California Ave., Bakersfield, CA 

93304, 661–322–4250/800–350–3515 

One Source Toxicology Laboratory, Inc., 

1213 Genoa-Red Bluff, Pasadena, TX 

77504, 888–747–3774, (Formerly: 

University of Texas Medical Branch, 

Clinical Chemistry Division; UTMB 

Pathology-Toxicology Laboratory) 

Pacific Toxicology Laboratories, 9348 

DeSoto Ave., Chatsworth, CA 91311, 

800–328–6942, (Formerly: Centinela 

Hospital Airport Toxicology 

Laboratory) 

Pathology Associates Medical 

Laboratories, 110 West Cliff Dr., 

Spokane, WA 99204, 509–755–8991/

800–541–7891x7 

Phamatech, Inc., 10151 Barnes Canyon 

Road, San Diego, CA 92121, 858–643– 

5555 

Quest Diagnostics Incorporated, 1777 

Montreal Circle, Tucker, GA 30084, 

800–729–6432, (Formerly: SmithKline 

Beecham Clinical Laboratories; 

SmithKline Bio-Science Laboratories) 

Quest Diagnostics Incorporated, 400 

Egypt Road, Norristown, PA 19403, 

610–631–4600/877–642–2216, 

(Formerly: SmithKline Beecham 

Clinical Laboratories; SmithKline BioScience Laboratories) 

Quest Diagnostics Incorporated, 8401 

Fallbrook Ave., West Hills, CA 91304, 

818–737–6370, (Formerly: SmithKline 

Beecham Clinical Laboratories) 

Redwood Toxicology Laboratory, 

3700650 Westwind Blvd., Santa Rosa, 

CA 95403, 800–255–2159 

Southwest Laboratories, 4625 E. Cotton 

Center Boulevard, Suite 177, Phoenix, 

AZ 85040, 602–438–8507/800–279– 

0027 

STERLING Reference Laboratories, 2617 

East L Street, Tacoma, Washington 

98421, 800–442–0438 

U.S. Army Forensic Toxicology Drug 

Testing Laboratory, 2490 Wilson St., 

Fort George G. Meade, MD 20755– 

5235, 301–677–7085 

* The Standards Council of Canada (SCC) 

voted to end its Laboratory Accreditation 

Program for Substance Abuse (LAPSA) 

effective May 12, 1998. Laboratories certified 

through that program were accredited to 

conduct forensic urine drug testing as 

required by U.S. Department of 

Transportation (DOT) regulations. As of that 

date, the certification of those accredited 

Canadian laboratories will continue under 

DOT authority. The responsibility for 

conducting quarterly performance testing 

plus periodic on-site inspections of those 

LAPSA-accredited laboratories was 

transferred to the U.S. HHS, with the HHS’ 

NLCP contractor continuing to have an active 

role in the performance testing and 

laboratory inspection processes. Other 

Canadian laboratories wishing to be 

considered for the NLCP may apply directly 

to the NLCP contractor just as U.S. 

laboratories do. 

Upon finding a Canadian laboratory to be 

qualified, HHS will recommend that DOT 

certify the laboratory (Federal Register, July 

16, 1996) as meeting the minimum standards 

of the Mandatory Guidelines published in the 

Federal Register on April 30, 2010 (75 FR 

22809). After receiving DOT certification, the 

laboratory will be included in the monthly 

list of HHS-certified laboratories and 

participate in the NLCP certification 

maintenance program. 

Janine Denis Cook, 

Chemist, Division of Workplace Programs, 

Center for Substance Abuse Prevention, 

SAMHSA. 

[FR Doc. 2014–28493 Filed 12–3–14; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF THE INTERIOR 

Fish and Wildlife Service 

[FWS–HQ–IA–2014–N248; 

FXIA16710900000–156–FF09A30000] 

Endangered Species; Marine 

Mammals; Issuance of Permits 

AGENCY: Fish and Wildlife Service, 

Interior. 

ACTION: Notice of issuance of permits. 

SUMMARY: We, the U.S. Fish and 

Wildlife Service (Service), have issued 

the following permits to conduct certain 

activities with endangered species, 

marine mammals, or both. We issue 

these permits under the Endangered 

Species Act (ESA) and Marine Mammal 

Protection Act (MMPA). 

ADDRESSES: Brenda Tapia, U.S. Fish and 

Wildlife Service, Division of 

Management Authority, Branch of 

Permits, MS: IA, 5275 Leesburg Pike, 

Falls Church, VA 22041; fax (703) 358– 

2281; or email DMAFR@fws.gov. 

FOR FURTHER INFORMATION CONTACT: 

Brenda Tapia, (703) 358–2104 

(telephone); (703) 358–2281 (fax); 

DMAFR@fws.gov (email). 

SUPPLEMENTARY INFORMATION: On the 

dates below, as authorized by the 

provisions of the ESA (16 U.S.C. 1531 

et seq.), as amended, and/or the MMPA, 

as amended (16 U.S.C. 1361 et seq.), we 

issued requested permits subject to 

certain conditions set forth therein. For 

each permit for an endangered species, 

we found that (1) The application was 

filed in good faith, (2) The granted 

permit would not operate to the 

disadvantage of the endangered species, 

and (3) The granted permit would be 

consistent with the purposes and policy 

set forth in section 2 of the ESA. 

Permit No. Applicant Receipt of application Federal Register notice Permit issuance date 

Endangered Species 

37543B .............. Byron Wates ............................... 79 FR 39409; July 10, 2014 ........................................................... September 16, 2014. 

40316B .............. Ramon Gonzalez ........................ 79 FR 52038; September 2, 2014 .................................................. September 2, 2014. 

39418B .............. Exotic Feline Breeding Compound Inc.79 FR 52038; September 2, 2014 .................................................. November 25, 2014. 

43610B .............. Exotic Feline Breeding Compound Inc.79 FR 52038; September 2, 2014 .................................................. November 25, 2014. 

mstockstill on DSK4VPTVN1PROD with NOTICES